$IBMBullishMed

IBM Jumps 7%; IonQ, Rigetti Sell Off as Quantum Trade Concentrates

IBM shares rose about 7% to around $320 after the company announced a $10 billion, five-year quantum computing commitment and a $1 billion CHIPS Act grant for its Anderon foundry, targeting fault-tolerant quantum computing by 2029. IonQ fell despite Q1 revenue of $64.67M (+755% YoY) and $260–270M guidance. Rigetti reported Q1 revenue of $4.4M and $569M cash, but shares declined.

Med
Bullish
pre-market today (early Monday trading)
Risk-on for IBM quantum exposure; risk-off for pure-play quantum peers (IONQ, RGTI)

Near-term momentum likely supported by capital concentration into IBM’s quantum roadmap and positive analyst framing.

IBM announced a $10B five-year quantum commitment plus a $1B CHIPS Act-backed Anderon foundry, driving a sharp +7% premarket move.

Bullish bias for the session/next few days, with upside tied to continued institutional follow-through.

Background

The piece frames a “quantum trade” where investors are concentrating capital into IBM’s quantum roadmap rather than spreading across smaller pure-play quantum companies.

Why it matters

IBM’s new $10B commitment and CHIPS Act-supported Anderon foundry appear to be the catalyst for the stock’s outsized move, while IONQ and RGTI react negatively despite strong/solid operational updates.

Market relevance

A single-company catalyst (IBM’s quantum/CHIPS-backed foundry) is reshaping relative flows across the quantum complex, pressuring IONQ and RGTI on the day.

Market effects

Signals capital rotation within quantum computing from speculative pure-plays toward a legacy platform player with government-backed infrastructure.

US-focused read-through as the move is driven by US-listed names and a US CHIPS Act grant.

Could influence global quantum funding narratives by highlighting state-backed foundry buildouts as a differentiator.

Alternative perspectives

The selloff in IONQ/RGTI may be positioning-driven rather than a deterioration in fundamentals, so weakness could be temporary if guidance is credible.

The article emphasizes relative performance versus IBM; traders should also watch for follow-on details on execution timelines (foundry ramp, qubit milestones) that can swing sentiment quickly.

Key entities

  • IBM

    Announced a $10B five-year quantum computing commitment anchored by Anderon and a $1B CHIPS Act grant.

  • IonQ

    Reported Q1 revenue $64.67M (+755% YoY) and full-year guidance $260–270M, but shares fell.

  • Rigetti Computing

    Reported Q1 revenue $4.4M, $569M cash, and UK expansion plans, but shares declined.

  • Anderon

    IBM-backed quantum chip foundry in New York supported by a $1B CHIPS Act grant (IBM matches funding).

Related articles

$IBMLow

Targeted News Service

IBM (NYSE: IBM) and Google Cloud announced a strategic partnership and the launch of a new Google Cloud Practice aimed at helping organizations scale AI into production and modernize their operations, according to the companies’ June 4 release. The firms said the effort combines human expertise with AI-powered delivery.

$DDOGMed

Stocks Retreat as US-Iran Peace Hopes in Doubt

US stocks retreated as markets scaled back hopes for US-Iran peace. US MBA mortgage applications fell 2.5% (purchase -2.9%, refi -2.3%); the 30-year fixed rate dropped 8 bp to 6.57%. The Fed Beige Book was hawkish, citing slight-to-moderate growth and higher inflation; John Williams said no rate change is needed. Traders priced a 3% chance of a 25 bp hike.

$IONQLow

What a $1,000 Bet on IonQ Since Its SPAC Debut Is Worth Today

IonQ (NYSE:IONQ) began trading in Oct. 2021 after a SPAC merger with dMY Technology Group III. The article says a $1,000 investment at $9.20 would be worth $7,760 today (+676%), outperforming the S&P 500. It also cites IonQ as the first quantum firm to exceed $100M annual GAAP revenue; Q1 FY26 sales rose 755% YoY to $64.67M. Risks noted include a $512M FY25 net loss and valuation at 139x sales.

$RGTIMed

Why Rigetti Computing Stock Gained 46.4% In May

Rigetti Computing shares rose more than 46% in May, helped by a Nasdaq rally and company-specific catalysts. The U.S. Department of Commerce signed CHIPS Act letters of intent for up to $2B in grants; Rigetti is set to receive up to $100M over three years, according to the government. Rigetti also reported Q1 2026 revenue of $4.4M (nearly triple YoY) and launched its Cepheus 108-qubit system, though free cash flow was -$20.6M.

$TEAMMed

Stocks Pressured as Middle East Flare-Ups Boost Crude Oil

Overseas markets were mixed: Euro Stoxx 50 fell 0.63%, China’s Shanghai Composite rose 0.22%, and Japan’s Nikkei hit a record up 2.50%. US 10-year yields rose to 4.489% after US-Iran tensions pushed WTI up 1% and May ADP employment surprised higher. Stocks: software and private credit slid; chipmakers gained.